REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN AND DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 25, 2023
Last action Jan 30, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jan 30, 2023
Senate · Referred to committee
Referred to HHS.
Jan 25, 2023
Senate · Introduced
Offered.
2 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Karl Rhoads
DDemocratic
P
Stanley Chang
DDemocratic
Co
Angus McKelvey
DDemocratic
Co
Maile Shimabukuro
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SR 3
Scope: HI
Hi! I can help you understand SR 3. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline